Gait patterns associated with thyroid function: The Rotterdam Study by Bano, A. (Arjola) et al.
1Scientific RepoRts | 6:38912 | DOI: 10.1038/srep38912
www.nature.com/scientificreports
Gait patterns associated with 
thyroid function: The Rotterdam 
Study
Arjola Bano1,2,3, Layal Chaker1,2,3,4, Sirwan K. L. Darweesh3,4, Tim I. M. Korevaar1,2, 
Francesco U. S. Mattace-Raso1,5, Abbas Dehghan3, Oscar H. Franco3, Jos N. van der Geest6, 
M. Arfan Ikram3,7,8 & Robin P. Peeters1,2,3
Gait is an important health indicator and poor gait is strongly associated with disability and risk of 
falls. Thyroid dysfunction is suggested as a potential determinant of gait deterioration, but this has 
not been explored in a population-based study. We therefore investigated the association of thyroid 
function with gait patterns in 2645 participants from the Rotterdam Study with data available on 
TSH (thyroid-stimulating hormone), FT4 (free thyroxine) and gait, without known thyroid disease or 
dementia. The primary outcome was Global gait (standardized Z-score), while secondary outcomes 
included gait domains (Rhythm, Variability, Phases, Pace, Base of support, Tandem, Turning) and 
velocity. Gait was assessed by electronic walkway. Multivariable regression models revealed an inverted 
U-shaped association of TSH (p < 0.001), but no association of FT4 concentrations with Global gait 
(p = 0.2). TSH levels were positively associated with Base of support (p = 0.01) and followed an inverted 
U-shaped curve with Tandem (p = 0.002) and velocity (p = 0.02). Clinical and subclinical hypothyroidism 
were associated with worse Global gait than euthyroidism (β = −0.61; CI = −1.03, −0.18; p = 0.004 
and β = −0.13; CI = −0.26, −0.00; p = 0.04, respectively). In euthyroid participants, higher thyroid 
function was associated with worse gait patterns. In conclusion, both low and high thyroid function are 
associated with alterations in Global gait, Tandem, Base of support and velocity.
Gait is an important marker of general health. Disturbances in gait gradually increase with advancing age and 
affect approximately one third of community-dwelling individuals older than 60 years1. Gait impairment has 
a substantial impact on quality of life and is strongly associated with increased risk of falls, which can in turn 
cause soft-tissue injuries, fractures and death2,3. Quantitative gait assessment comprises many parameters that 
can be summarized into seven independent domains, namely Rhythm, Variability, Phases, Pace, Base of support, 
Tandem and Turning (Fig. 1)4,5. These gait domains reflect distinct functional abilities and their investigation is 
crucial to identify novel modifiable contributors to gait deterioration5.
Thyroid hormones regulate metabolism in most tissues, including neurological and musculoskeletal sys-
tems, whose integrated functioning is reflected in gait6–8. As gait disturbances, thyroid dysfunction increases in 
prevalence with advancing age. However, the clinical symptoms of thyroid dysfunction become less pronounced 
among older adults9 and this may result in a diagnostic delay and increased risk of systemic complications. 
Research to date has suggested a possible role of thyroid dysfunction in gait impairment. Adult mice lacking the 
thyroid-hormone activating enzyme type 2 deiodinase have shown progressive gait impairment in the late stages 
of life10. In humans, several case series11,12 and case reports13–15 have shown a restoration of gait disturbances after 
treatment of thyroid disease.
Thyroid function in the general population has been linked to gait velocity, which constitutes only one of the 
parameters in the Pace domain16,17. However, the link of thyroid function with gait and its spatiotemporal aspects 
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remains unexplored. Therefore, we aimed to investigate the association of thyroid function with Global gait and 
its separate domains, in a large population-based cohort of middle-aged and elderly subjects.
Results
We included a total of 2645 eligible participants with data available on thyroid function and gait, without known 
thyroid disease or dementia (Supplementary Figure 1). The baseline characteristics of the study population are 
shown in Table 1. The mean age was 59.6 years and 52.6% were females (Table 1).
The association of thyroid function with Global gait. Our results did not change after primary and 
additional adjustments for potential confounders; therefore we further report only the most adjusted model 
Figure 1. Normal walk, Turning and Tandem. The three walking conditions, including five gait domains for 
normal walk (Rhythm, Variability, Phases, Pace, Base of support), one for turn (Turning) and one for tandem 
walk (Tandem).
Characteristics Mean (sd)*
Age, years 59.6 (6.6)
Female, n (%) 1392 (52.6)
Smoking, n (%)
 current 561 (21.2) 561 (21.2)
 past 1242 (47.0) 1242 (47.0)
 never 842 (31.8) 842 (31.8)
Alcohol intake > 14 drinks/week, n (%) 565 (21.4)
Education level, n (%)
 low 195 (7.4)
 intermediate 1821 (68.8)
 high 629 (23.7)
Height, cm 170.0 (9.2)
Weight, kg 78.4 (14.1)
Knee pain or stiffness, n (%) 693 (26.2)
Hip pain or stiffness, n (%) 401 (15.2)
Past stroke, n (%) 66 (2.5)
CESD depressive symptoms, n (%) 298 (11.3)
Cerebellar cortical volume, ml 99.3 (10.6)
Intracranial volume, ml 1479.6 (159.6)
TSH, mIU/L, median (IQR) 1.9 (1.3–2.8)
FT4, pmol/L 15.5 (2.1)
TPOAb positive, n (%) 312 (11.8)
Table 1.  Baseline characteristics of 2645 participants. *Data are mean (sd), unless otherwise specified. 
Abbreviations: sd, standard deviation; CESD, Centre for Epidemiological Studies Depression Scale; TSH, 
thyroid-stimulating hormone; IQR, interquartile range; FT4, free thyroxine; TPOAb, thyroid peroxidase 
antibodies (cutoff 35 kU/ml).
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(Model 2). TSH concentrations within the full range followed an inverted U-shaped curve with respect to 
Global gait (p-value < 0.001) (Fig. 2a). However, there was no association of FT4 concentrations with Global 
gait (p = 0.2) (Fig. 2b). When we restricted the analysis to euthyroid participants, higher TSH concentrations 
were associated with a better Global gait (β , 0.08; 95% confidence interval [CI], 0.02 to 0.13 per 1 unit logTSH; 
p = 0.006) (Supplementary Table S1). Moreover, there was a borderline statistically significant association 
between FT4 levels within the normal range and Global gait (β = − 0.05; CI = − 0.10 to 0.00 per 1 pmol/L FT4; 
p = 0.05) (Supplementary Table S1). Clinical and subclinical hypothyroidism were associated with a worse Global 
gait than euthyroidism (β = − 0.61; CI = − 1.03 to − 0.18; p = 0.004 and β , − 0.13; CI, − 0.26 to − 0.00; p = 0.04 
respectively) (Fig. 3a). No association was observed between TPOAb and Global gait in the main analysis or after 
restricting to euthyroid participants (Supplementary Table S2). Results remained similar after excluding partici-
pants with prevalent stroke and Parkinson’s disease (Supplementary Figure 2).
The associations of thyroid function with gait domains and gait velocity. TSH levels were posi-
tively linearly associated with Base of support (p = 0.01) (Fig. 4e) and followed an inverted U-shaped curve with 
respect to Tandem (p = 0.002) (Fig. 4f) and gait velocity (p = 0.02) (Fig. 2c). In euthyroid participants, higher TSH 
levels were associated with higher Base of support (β = 0.07; CI = 0.01 to 0.14; p = 0.01) and Tandem (β = 0.06; 
CI = 0.01 to 0.12; p = 0.04), whereas higher FT4 levels were associated with lower gait velocity (β = − 0.96; CI = 
− 1.85 to − 0.07; p = 0.03) (Supplementary Table S1). Clinical and subclinical hypothyroidism were associated 
with lower gait velocity than euthyroidism, with borderline statistical significance (β = − 7.11; CI = − 14.69 to 
0.49; p = 0.06 and β = − 2.22; CI = − 4.50 to 0.05; p = 0.05, respectively) (Fig. 3b). Gait velocity decreased gradu-
ally from euthyroidism to clinical hypothyroidism (p-trend 0.01) (Fig. 3b).
Discussion
In a large cohort of middle-aged and elderly subjects, we reported an inverted U-shaped association between TSH 
concentrations and Global gait, indicating that both low and high thyroid function are associated with worse gait. 
Figure 2. Association of thyroid function with Global gait and velocity. Adjusted for age, sex, cohort, 
smoking, alcohol intake, education level, height, weight, time interval between thyroid function measurement 
and gait assessment, knee pain or stiffness, hip pain or stiffness, prevalent stroke, CESD depression score, 
cerebellar cortical volume, intracranial volume, thyroid peroxidase antibodies. We utilized linear regression 
models with restricted cubic splines. TSH/FT4 concentrations are plotted against predicted means of Z-score 
Global gait and velocity (black lines) with 95% CI (gray areas). Dashed lines indicate the limits of TSH or FT4 
reference ranges. A higher value of Global gait represents better gait.
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TSH levels were positively associated with Base of support and followed an inverted U-shaped curve with Tandem 
and gait velocity. In euthyroid subjects, higher thyroid function was associated with worse gait patterns.
The association between thyroid function and gait could be explained by different pathophysiological mecha-
nisms, particularly involving the neurological and musculoskeletal systems. Low and high thyroid function may 
increase the risk of stroke via unfavorable cardiovascular risk profile and atrial fibrillation, respectively18,19. Low 
thyroid function can additionally induce immune-mediated cerebellar degeneration14. Furthermore, low and 
high thyroid function can lead to a dysregulation of the neurotransmission systems and subsequent depressive 
symptoms20. Low and high thyroid function may also contribute to myopathy and fractures, by affecting muscle 
mass and bone mineral density21,22. In turn, stroke, cerebellar degeneration, depression, myopathy and fractures 
are all implicated in gait deterioration14,18–22. In our study, adjustments for stroke, cerebellar cortical volume, 
TPOAb, CESD depression score, hip and knee pain or stiffness (proxy for musculoskeletal dysfunction) did not 
change the results, suggesting that the association between thyroid function and gait patterns is independent of 
these factors. Alternative underlying pathways can explain the association. The most plausible may be peripheral 
neuropathy, since thyroid dysfunction has been commonly associated with axonal degeneration and nerve con-
duction abnormalities21,23,24. Both hypothyroid and hyperthyroid patients usually experience symmetric distal 
sensory disturbances that can resolve after treatment of thyroid dysfunction21,25. Also, genetic disorders affecting 
thyroid hormone transport and metabolism may play a role in gait impairment26. However, the exact mechanisms 
through which thyroid function could affect the gait patterns remain unexplored and further studies should be 
directed towards unravelling the underlying pathophysiology.
Although gait is a multidimensional concept, gait assessment in prior comparable studies has been limited to 
the measurement of gait velocity16,17. A relatively small study (n = 602) reported an association of high-normal 
FT4 levels with slower walk17. A second study reported a faster walk in individuals with mildly elevated TSH lev-
els (4.5–7.0 mU/L) compared with euthyroid individuals16. Our conclusions are in line with the results of the first 
study, but do not support those of the second study. Most likely, the discrepancy between our results and those of 
the second study may be attributable to differences in TSH reference ranges and thyroid status definitions. In the 
second study, participants with TSH levels between 4.5 and 7.0 mIU/L were considered to have mild subclinical 
hypothyroidism, though they lacked FT4 measurements. Instead, we used both TSH and FT4 measurements 
to define the thyroid status of our participants. Therefore, our conclusions may add valuable information to the 
ongoing debate on the effects of untreated or undetected subclinical hypothyroidism. Most importantly, our large 
population-based cohort study extends the previous literature by addressing for the first time the association of 
thyroid function with Global gait and gait domains. Our results indicate the importance of comprehensive gait 
evaluation, as we observe a stronger association of thyroid status with Global gait than with gait velocity.
We were able to identify Tandem, Base of Support and gait velocity as spatiotemporal gait aspects related to 
thyroid function. Likewise, past case reports have described hypothyroid patients with a “wide-based gait” and 
tandem walking errors on neurological examination12–15. In addition, adult mice lacking type 2 deiodinase walked 
slower and with wider base of support than the wild-type mice10. Our results confirm these findings in the setting 
Figure 3. Association of thyroid status categories with Global gait and velocity. Adjusted for age, sex, cohort, 
smoking, alcohol intake, education level, height, weight, time interval between thyroid function measurement 
and gait assessment, knee pain or stiffness, hip pain or stiffness, prevalent stroke, CESD depression score, 
cerebellar cortical volume, intracranial volume, thyroid peroxidase antibodies. Thyroid status categories 
are plotted against differences in Z score of Global gait and velocity, with euthyroid subjects as reference. 
Euthyroidism was defined as TSH (thyroid-stimulating hormone) within reference range (0.4–4.0 mIU/l); 
clinical hypothyroidism as TSH > 4.0 mU/L and FT4 (free thyroxine) < 11 pmol/L; subclinical hypothyroidism 
as TSH > 4.0 mU/L and FT411-25 pmol/L; clinical hyperthyroidism as TSH < 0.4 mU/L and FT4 > 25 pmol/L; 
subclinical hyperthyroidism as TSH < 0.4 mU/L and FT411-25 pmol/L. None of the participants had clinical 
hyperthyroidism. Error bars represent the 95% confidence intervals around the standardized β (black dots). 
Within brackets: Total number. A higher value of global gait represents better gait.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:38912 | DOI: 10.1038/srep38912
of a general population cohort study. Of note, the identification of thyroid-related gait domains may provide 
valuable hints on the pathways linking thyroid function to gait. Tandem, Base of Support and gait velocity have 
been associated with distinct brain structures (i.e. prefrontal regions, parietal cortex, pallidum, putamen, and 
cerebellum), executive functioning and balance, that might be specific targets of thyroid hormone action4,15,27–31.
A limitation of our study is its cross-sectional design, which does not enable us to draw conclusions on cau-
sality. Though it is more likely that thyroid function affects gait than vice-versa, one could also hypothesize that 
health problems underlying gait abnormalities may alter thyroid parameters in the setting of non-thyroidal illness 
syndrome (NTIS). This condition is characterized by low thyroid hormones and normal TSH levels32. Instead, 
we reported a non-linear association between TSH levels and Global gait. Also, NTIS is typical in critically ill 
patients, whereas the RS consists of community-dwelling adults32. Therefore, NTIS is unlikely to be the expla-
nation of our findings. Furthermore, turning and tandem walk lacked repeated measurements, which would 
have reduced the intra-individual variability. However, we did perform up to eight consecutive recordings of 
the normal walk and used a well validated instrument for an objective gait evaluation in three walking condi-
tions. Also, the RS does not have data available on serum triiodothyronine levels, which is a limitation for most 
population-based studies. However, TSH and FT4 concentrations are considered as the most relevant measure-
ments of thyroid function in clinical practice. Moreover, RS includes predominantly Caucasians over 45 years old, 
which limits the generalizability of our findings to other populations. Lastly, the possibility of residual confound-
ing cannot be excluded, even though we controlled for multiple potential confounders.
In summary, both low and high thyroid function are associated with worse gait patterns. There is an inverted 
U-shaped association of TSH levels with Global gait, Tandem and gait velocity, as well as a positive association of 
TSH levels with Base of support. Subjects with clinical and subclinical hypothyroidism have worse gait patterns 
than euthyroid individuals. These conclusions might have future implications regarding the prevention and treat-
ment of thyroid and gait disorders. Further studies are needed to confirm our findings, determine the underlying 
mechanisms linking thyroid function to gait patterns and subsequently investigate the possible motor benefits of 
thyroid treatment.
Figure 4. Association of TSH with the seven gait domains. Adjusted for age, sex, cohort, smoking, alcohol 
intake, education level, height, weight, time interval between thyroid function measurement and gait 
assessment, knee pain or stiffness, hip pain or stiffness, prevalent stroke, CESD depression score, cerebellar 
cortical volume, intracranial volume, thyroid peroxidase antibodies. The model including Tandem walk was 
additionally adjusted for step count and mean step size. Point estimates are reported as predicted means (black 
lines) of gait domains with 95% CI (gray areas). A higher value of gait domains represents better gait.
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Materials and Methods
Study population. The Rotterdam Study (RS) is an ongoing prospective population-based cohort study that 
investigates chronic diseases in the middle-aged and elderly. The objectives and study design of RS have been 
described in detail elsewhere33. RS was initiated in 1990, including 7983 participants aged 55 years or older (RS I). 
In 2000, the cohort was expanded with 3011 participants aged 55 or older (RS II). In 2006, a third cohort of 3932 
participants aged 45 years and over was added (RS III). As of now, RS comprises a total of 14926 participants, 
who undergo extensive follow-up medical examinations every 2 to 4 years. From 2009 onwards, quantitative gait 
assessment was included in the study protocol. Between March 2009 and March 2012, 3651 participants of the RS 
were invited for gait assessment. An overview on the selection of study participants can be found in the flowchart 
(Supplementary Figure 1).
The Medical Ethics Committee of the Erasmus University and the Ministry of Health, Welfare and Sport 
of the Netherlands have approved the study protocols, implementing the “Wet Bevolkingsonderzoek: ERGO 
(Population Studies Act: Rotterdam Study)”. The methods were performed in accordance with the approved 
guidelines. All included participants provided written informed consent in accordance with the Declaration of 
Helsinki.
Population for analysis. A total of 2857 subjects had complete information on thyroid function and gait. 
Of these, we excluded 212 subjects with at least one out of several conditions: 1) dementia diagnosis (n = 14); 2) 
thyroid medication usage (n = 79); 3) history of thyroid disease (n = 192) and 4) previous thyroid surgery (n = 33) 
(Supplementary Figure 1). The remaining 2645 eligible participants were enrolled in the study.
Assessment of thyroid function. Thyroid function tests were performed in study cohorts RS I visit 3 
(RS I-3), RS II visit 1 (RS II-1) and RS III visit 1 (RS III.1) using the same method and assay. Concentrations 
of thyroid-stimulating hormone (TSH), free thyroxine (FT4) and thyroid peroxidase antibodies (TPOAb) 
were measured on baseline serum samples stored at − 80 °C using the electrochemiluminescence immuno-
assay, “ECLIA”, Roche. We determined the reference range of serum TSH as 0.40–4.0 mIU/L and serum FT4 
as 11–25 pmol/L (alternatively 0.86–1.94 ng/dL), according to national guidelines and our previous studies34,35. 
Euthyroidism was defined as serum TSH within the reference range. Subclinical hypothyroidism was defined 
as serum TSH > 4.0 mIU/L and FT4 levels within the reference range. Overt hypothyroidism was defined as 
serum TSH > 4.0 mIU/L and FT4 levels < 11 pmol/L. Subclinical hyperthyroidism was defined as serum 
TSH < 0.40 mIU/L and FT4 levels within the reference range. Overt hyperthyroidism was defined as serum 
TSH < 0.40 mIU/L and FT4 levels > 25 pmol/L. TPOAb positivity (reflecting thyroid autoimmunity) was 
defined as TPOAb levels above the cut-off of 35 kU/ml, in accordance with the recommendations of the assay 
manufacturer34,35.
Assessment of gait. Quantitative gait assessment was performed in study cohorts RS I visit 5 (RS I-5), RS II 
visit 3 (RS II-3) and RS III visit I (RS III.1). Gait was evaluated using a 5.79-m long walkway (GAITRite Platinum; 
CIR systems, Sparta, NJ: 4.88-m active area; 120-Hz sampling rate). The reliability and validity of this device have 
been previously established4,36–38. The standardized gait protocol comprises three walking conditions: normal 
walk, turning and tandem walk (Fig. 1). In the normal walk, participants walked at their usual pace across the 
walkway. This walk was repeated eight times, of which the first recording was considered a practice walk and 
excluded from the analyses. In turning, participants walked at their usual pace, turned halfway, and returned to 
the starting position. In the tandem walk, participants walked heel-to-toe on a line across the walkway. Based 
on the recorded footfalls, the walkway software calculated thirty gait parameters, including twenty five from the 
normal walk, two from turning and three from the tandem walk. Subsequently, principal component analysis 
(PCA) was performed to avoid multiple testing and collinearity across the variables. While capturing the largest 
amount of variance, PCA summarizes gait parameters into seven independent gait domains: Rhythm, Variability, 
Phases, Pace, Base of Support, Tandem and Turning5. Rhythm reflects cadence and stride time; Variability reflects 
variations in length and time among strides; Phases reflects double support time and double support as a percent-
age of the gait cycle; Pace reflects stride length and gait velocity; Base of Support reflects stride width and stride 
width variability; Tandem reflects errors in tandem walking; Turning reflects turning time and the number of 
turn steps5. When necessary, gait domains were inverted so that lower values represent “worse” gait. Global gait 
was calculated by averaging gait domains into a standardized Z-score5. Gait velocity was additionally included in 
our analysis in order to compare our findings with previous studies investigating the association between thyroid 
function and gait velocity16,17.
Assessment of covariates. The baseline home interview provided information on medical history, tobacco 
smoking, alcohol consumption, education level, medication, knee and hip pain or stiffness. Participants were cat-
egorized based on their smoking status (current, past and never smokers) and education level (low, intermediate 
and high). Height and weight were measured during the examinations at the research center. Stroke cases were 
reviewed and verified by an experienced vascular neurologist using hospital letters, information from practition-
ers and nursing home physicians. Depressive disorders were evaluated based on the Centre for Epidemiological 
Studies Depression Scale (CESD) questionnaire. A score above 16 was considered indicative of a depressive dis-
order39. Cerebellar cortical volume and intracranial volume were examined by standardized magnetic resonance 
imaging (MRI) scanning of the brain33.
Statistical analysis. We investigated the association of thyroid parameters (TSH, FT4 and TPOAb positivity) 
with Global gait and spatiotemporal gait components, by performing ordinary least-squares linear regression. 
The primary outcome was Global gait, while secondary outcomes included gait domains (i.e. Rhythm, Variability, 
Phases, Pace, Base of support, Tandem and Turning) and gait velocity. We fitted restricted cubic splines to allow 
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for potential nonlinearity. Moreover, we evaluated Global gait and gait velocity throughout thyroid function cat-
egories, with euthyroid subjects as reference group. Next, we examined the association of thyroid function with 
gait in euthyroid participants. In addition, we performed a sensitivity analysis excluding participants with preva-
lent stroke (n = 66) and Parkinson’s disease (n = 3).
All analyses were adjusted for potential confounding by age, sex, cohort, smoking status, alcohol intake 
(Model 1). As thyroid function measurement preceded the gait assessment, we also adjusted for the time interval 
between measurements. In Model 2, we additionally adjusted for covariates that could be either confounders or 
mediators, including education level, height, weight, knee pain or stiffness, hip pain or stiffness, prevalent stroke, 
CESD depression score, cerebellar cortical volume, intracranial volume, TPOAb concentrations. Step count and 
mean step size can affect the score of Tandem walk. Therefore, all models including Tandem walk were further 
adjusted for step count and mean step size.
TSH values were logarithmically transformed, because of its skewed distribution. The assumption of normally 
distributed residuals was checked and met. All models were tested for effect modification by separately adding 
product interaction terms of the exposure (TSH or FT4 or TPOAb) with covariates of the multivariable model, 
but none of the interaction terms were significant. Multiple imputations were performed for covariates with miss-
ing data (less than 4.6% for all covariates). A p-value (two-tailed) < 0.05 was considered statistically significant. 
Statistical analyses were conducted using R statistical software (rms-package, R-project, Institute for Statistics and 
Mathematics, R Core Team, Vienna, Austria, version 3.2.2) and IBM SPSS version 21 (IBM Corp).
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